These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21666738)
1. Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection. Grigoriadis G; Chang CC; Walker P; Patil S; Avery S; Morrissey O; Spencer A Bone Marrow Transplant; 2012 Apr; 47(4):591-2. PubMed ID: 21666738 [No Abstract] [Full Text] [Related]
2. High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole. Eibl M; Auner HW; Zinke-Cerwenka W; Sill H; Dornbusch HJ; Linkesch W Ann Hematol; 2004 Feb; 83(2):133-6. PubMed ID: 14530879 [TBL] [Abstract][Full Text] [Related]
3. [Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia]. Shindo M; Sato K; Jimbo J; Hosoki T; Ikuta K; Sano A; Nishimura K; Torimoto Y; Kohgo Y Rinsho Ketsueki; 2007 May; 48(5):412-7. PubMed ID: 17571588 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis. Schneidawind D; Nann D; Vogel W; Faul C; Fend F; Horger M; Kanz L; Bethge W Transpl Infect Dis; 2012 Dec; 14(6):E166-72. PubMed ID: 23075207 [TBL] [Abstract][Full Text] [Related]
5. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study. Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283 [TBL] [Abstract][Full Text] [Related]
6. [Two cases of mycoses associated with hematologic disease]. Kida M Jpn J Antibiot; 2008 Oct; 61(5):353-4. PubMed ID: 19343837 [No Abstract] [Full Text] [Related]
7. Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation. Ustun C; Farrow S; DeRemer D; Fain H; Jillella AP Bone Marrow Transplant; 2007 Jun; 39(12):807-8. PubMed ID: 17438583 [No Abstract] [Full Text] [Related]
8. On the Nose: Disseminated Mucormycosis. Danneels P; Mahieu R; Dib M; Abgueguen P; Rabier V; Klosek M; Le Govic Y; Dubée V Am J Med; 2018 Oct; 131(10):1182-1184. PubMed ID: 29806997 [No Abstract] [Full Text] [Related]
9. Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Brown J; Freeman BB Bone Marrow Transplant; 2005 Jul; 36(2):177. PubMed ID: 15908975 [No Abstract] [Full Text] [Related]
10. Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy. Aoki T; Miyamoto T; Mori Y; Yoshimoto G; Yamauchi T; Kamezaki K; Takenaka K; Iwasaki H; Harada N; Nagafuji K; Shimono N; Teshima T; Akashi K Mycoses; 2011 Jul; 54(4):e255-9. PubMed ID: 20236243 [TBL] [Abstract][Full Text] [Related]
11. Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia. Torres A; Serrano J; Rojas R; Martín V; Martín C; Tabares S; Molina JR; Capote M; Martínez F; Gómez P; Sánchez-García J Eur J Haematol; 2010 Mar; 84(3):271-3. PubMed ID: 19878274 [No Abstract] [Full Text] [Related]